Is DiaMedica Therapeutics Inc. (DMAC) a Buy, Sell, or Hold?
NASDAQ : DMAC
DiaMedica Therapeutics Inc.
$7.13 USD
-$0.51 (-6.68%)
- Volume
- 158.62K
- Average Volume
- 199.28K
- Market Capitalization
- $384.19M
- P/E Ratio
- -10.76
- Dividend Yield
- 0.00%
- Price Target
- $8.00
- Year High
- $10.42
- Year Low
- $3.65
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.11
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
33
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
3
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$41000
DMAC Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
DMAC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Parsons James T. | director | 2026-01-02 | A-Award | 8.42 | 2026-01-06 |
| Giuffre Randall Michael | director | 2026-01-02 | A-Award | 8.42 | 2026-01-06 |
| Semba Charles Pauling | director | 2026-01-02 | A-Award | 8.42 | 2026-01-06 |
| STAHLBERG JAN | 10 percent owner | 2025-11-25 | P-Purchase | 8.5749 | 2025-12-08 |
| STAHLBERG JAN | 10 percent owner | 2025-11-24 | P-Purchase | 7.8931 | 2025-12-08 |
| STAHLBERG JAN | 10 percent owner | 2025-11-21 | P-Purchase | 7.4092 | 2025-12-08 |
| STAHLBERG JAN | 10 percent owner | 2025-11-20 | P-Purchase | 7.4067 | 2025-12-08 |
| STAHLBERG JAN | 10 percent owner | 2025-11-19 | P-Purchase | 7.2076 | 2025-12-08 |
| STAHLBERG JAN | 10 percent owner | 2025-11-18 | P-Purchase | 6.7509 | 2025-12-08 |
| STAHLBERG JAN | 10 percent owner | 2025-11-17 | P-Purchase | 6.5166 | 2025-12-08 |
| Parsons James T. | director | 2025-11-21 | M-Exempt | 2.2 | 2025-11-25 |
| Parsons James T. | director | 2025-11-21 | M-Exempt | 2.2 | 2025-11-25 |
| Krop Julie | officer: Chief Marketing Officer | 2025-08-11 | A-Award | 4.58 | 2025-11-03 |
| Krop Julie | 2025-08-11 | 0 | 2025-11-03 | ||
| STAHLBERG JAN | 10 percent owner | 2025-08-27 | P-Purchase | 6 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-08-26 | P-Purchase | 6 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-08-25 | P-Purchase | 5.999 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-08-22 | P-Purchase | 5.964 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-08-21 | P-Purchase | 5.9584 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-08-20 | P-Purchase | 5.8573 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-08-15 | P-Purchase | 6 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-08-14 | P-Purchase | 5.992 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-08-13 | P-Purchase | 5.9091 | 2025-09-04 |
| STAHLBERG JAN | 10 percent owner | 2025-07-23 | P-Purchase | 3.5 | 2025-07-25 |
| Von Koch Thomas | 10 percent owner | 2025-07-23 | P-Purchase | 3.5 | 2025-07-25 |
| JACINTO RICHARD II | 10 percent owner | 2025-07-23 | P-Purchase | 3.5 | 2025-07-25 |
| Wambeke David J. | officer: Chief Business Officer | 2025-06-01 | A-Award | 4.11 | 2025-06-03 |
| Semba Charles Pauling | director | 2025-06-01 | A-Award | 4.11 | 2025-06-03 |
| Pauls Dietrich John | director, officer: President & CEO | 2025-06-01 | A-Award | 4.11 | 2025-06-03 |
| Parsons James T. | director | 2025-06-01 | A-Award | 4.11 | 2025-06-03 |
| Lewis Tanya | director | 2025-06-01 | A-Award | 4.11 | 2025-06-03 |
| Kuntz Richard | director | 2025-06-01 | A-Award | 4.11 | 2025-06-03 |
| Kellen Scott | officer: CFO & Secretary | 2025-06-01 | A-Award | 4.11 | 2025-06-03 |
| Giuffre Randall Michael | director | 2025-06-01 | A-Award | 4.11 | 2025-06-03 |
| Pilnik Richard D. | director | 2025-04-07 | M-Exempt | 2.11 | 2025-04-08 |
| Pilnik Richard D. | director | 2025-04-07 | M-Exempt | 2.11 | 2025-04-08 |
| O'Connor Daniel J. | director | 2025-02-20 | A-Award | 6.61 | 2025-02-24 |
| O'Connor Daniel J. | director: | 2025-02-20 | 0 | 2025-02-24 | |
| Giuffre Randall Michael | director | 2025-02-13 | M-Exempt | 3.65 | 2025-02-18 |
| Giuffre Randall Michael | director | 2025-02-13 | M-Exempt | 2.11 | 2025-02-18 |
| Giuffre Randall Michael | director | 2025-02-13 | M-Exempt | 2.11 | 2025-02-18 |
| Giuffre Randall Michael | director | 2025-02-13 | M-Exempt | 3.65 | 2025-02-18 |
| Parsons James T. | director | 2025-01-02 | A-Award | 5.34 | 2025-01-03 |
| Parsons James T. | director | 2025-01-02 | A-Award | 5.51 | 2025-01-03 |
| Giuffre Randall Michael | director | 2025-01-02 | A-Award | 5.34 | 2025-01-03 |
| Kuntz Richard | director | 2025-01-02 | A-Award | 5.34 | 2025-01-03 |
| Pilnik Richard D. | director | 2025-01-02 | A-Award | 5.34 | 2025-01-03 |
| Semba Charles Pauling | director | 2025-01-02 | A-Award | 5.34 | 2025-01-03 |
| Von Koch Thomas | 10 percent owner | 2024-06-28 | P-Purchase | 2.5 | 2024-07-01 |
| STAHLBERG JAN | 10 percent owner | 2024-06-28 | P-Purchase | 2.5 | 2024-07-01 |
| Wambeke David J. | officer: Chief Business Officer | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Kellen Scott | officer: CFO and Secretary | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Cundari Dominic R | officer: Chief Commercial Officer | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Pauls Dietrich John | director, officer: President and CEO | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Semba Charles Pauling | director | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Pilnik Richard D. | director | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Parsons James T. | director | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Lewis Tanya | director | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Kuntz Richard | director | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Giuffre Randall Michael | director | 2024-06-01 | A-Award | 2.9 | 2024-06-03 |
| Lorianne Masuoka K. | officer: Chief Medical Officer | 2024-01-22 | A-Award | 2.79 | 2024-01-23 |
| Lorianne Masuoka K. | officer | 2024-01-22 | 0 | 2024-01-23 | |
| Semba Charles Pauling | director | 2024-01-02 | A-Award | 2.8 | 2024-01-02 |
| Kuntz Richard | director | 2024-01-02 | A-Award | 2.8 | 2024-01-02 |
| Pilnik Richard D. | director | 2024-01-02 | A-Award | 2.8 | 2024-01-02 |
| Parsons James T. | director | 2024-01-02 | A-Award | 2.8 | 2024-01-02 |
| Giuffre Randall Michael | director | 2024-01-02 | A-Award | 2.8 | 2024-01-02 |
| Wambeke David J. | officer: Chief Business Officer | 2023-11-16 | P-Purchase | 2.46 | 2023-11-16 |
| Von Koch Thomas | 10 percent owner | 2023-06-23 | P-Purchase | 3.4 | 2023-06-27 |
| STAHLBERG JAN | 10 percent owner | 2023-06-23 | 0 | 2023-06-27 | |
| Giuffre Randall Michael | director | 2023-06-23 | P-Purchase | 3.91 | 2023-06-26 |
| Giuffre Randall Michael | director | 2023-06-23 | G-Gift | 0 | 2023-06-26 |
| Pauls Dietrich John | director, officer: President and CEO | 2023-06-23 | P-Purchase | 3.91 | 2023-06-26 |
| Semba Charles Pauling | director | 2023-06-23 | P-Purchase | 3.91 | 2023-06-26 |
| Kellen Scott | officer: CFO and Secretary | 2023-06-23 | P-Purchase | 3.91 | 2023-06-26 |
| Wambeke David J. | officer: Chief Business Officer | 2023-06-23 | P-Purchase | 3.91 | 2023-06-26 |
| Pilnik Richard D. | director | 2023-06-23 | P-Purchase | 3.91 | 2023-06-26 |
| JACINTO RICHARD II | 10 percent owner | 2023-06-23 | 0 | 2023-06-23 | |
| Daves Julie VanOrsdel | officer: SVP Clinical Development Oper. | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Cundari Dominic R | officer: Chief Commercial Officer | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Gruis Kirsten L | officer: Chief Medical Officer | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Kellen Scott | officer: CFO and Secretary | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Pauls Dietrich John | director, officer: President and CEO | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Semba Charles Pauling | director | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Pilnik Richard D. | director | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Parsons James T. | director | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Lewis Tanya | director | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Giuffre Randall Michael | director | 2023-06-01 | A-Award | 2.73 | 2023-06-02 |
| Kuntz Richard | director | 2023-05-30 | A-Award | 2.81 | 2023-05-30 |
| Kuntz Richard | director: | 2023-05-30 | 0 | 2023-05-30 | |
| Wambeke David J. | officer: Chief Business Officer | 2023-04-10 | P-Purchase | 1.6 | 2023-04-11 |
| Wambeke David J. | officer: Chief Business Officer | 2023-04-10 | A-Award | 1.57 | 2023-04-11 |
| Wambeke David J. | officer | 2023-04-10 | 0 | 2023-04-11 | |
| Lewis Tanya | director | 2023-03-01 | A-Award | 1.77 | 2023-03-06 |
| Lewis Tanya | director | 2023-03-01 | 0 | 2023-03-06 | |
| Giuffre Randall Michael | director | 2023-01-03 | A-Award | 1.53 | 2023-01-03 |
| Burroughs Amy L. | director | 2023-01-03 | A-Award | 1.53 | 2023-01-03 |
| Semba Charles Pauling | director | 2023-01-03 | A-Award | 1.53 | 2023-01-03 |
| Pilnik Richard D. | director | 2023-01-03 | A-Award | 1.53 | 2023-01-03 |
| Giuffre Randall Michael | director | 2022-12-09 | P-Purchase | 1.43 | 2022-12-12 |